TJM Labs provides AI-driven automation software that helps pharmacies automate repetitive, high-volume tasks without replacing existing systems. It uses AI agents that plug into current pharmacy management systems to handle prescription intake, data entry, fax processing, refill management, prior authorization, and patient communications. Each deployment uses the Dual-Expert Model, pairing a pharmacist with an AI engineer to tailor automation to real-world workflows and ensure clinical accuracy and compliance. TJM Labs targets independent, specialty, compounding, and enterprise pharmacies in the US and Canada, offering AI-as-a-service that reduces manual data entry and frees pharmacists to focus on patient care, with growth supported by acquisitions like EncoreRx and Pharmesol.
Company Size
51-200
Company Stage
Series B
Total Funding
$75M
Headquarters
Wilmington, Delaware
Founded
2024
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?